Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAE1 | Q13564 | 5/20 | 0.37 |
| ▸ | UBA3 | Q8TBC4 | 5/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | JAK1 | P23458 | 1/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.31 |
| ▸ | UBA2 | Q9UBT2 | 2/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10149582 | 0.88 | JAK2 (0.32) | JAK2JAK1GPR119 | |
| SCHEMBL865900 | 0.87 | JAK2 (0.32) | JAK2JAK1GPR119 | |
| SCHEMBL865901 | 0.87 | JAK2 (0.32) | JAK2JAK1GPR119 | |
| SCHEMBL866507 | 0.84 | NAE1 (0.44) | NAE1UBA3SAE1UBA2 | |
| SCHEMBL865836 | 0.84 | NAE1 (0.44) | NAE1UBA3SAE1UBA2 | |
| SCHEMBL867174 | 0.83 | NAE1 (0.44) | NAE1UBA3SAE1UBA2 | |
| SCHEMBL867353 | 0.83 | NAE1 (0.44) | NAE1UBA3SAE1UBA2 | |
| SCHEMBL866982 | 0.83 | GPR119 (0.35) | NAE1UBA3JAK2JAK1GPR119 | |
| SCHEMBL867408 | 0.81 | JAK2 (0.31) | JAK2JAK1 | |
| SCHEMBL10184262 | 0.72 | JAK2 (0.33) | JAK2JAK1GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077814-A1 | SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES | WANG ZHONG (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077814-A1 | SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES | NEDD8, NAE1, UBA3 | NAE1 2/4885UBA3 3/4885JAK2 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.